Yayıncı "Future Medicine Ltd" Dahili Tıp Bilimleri Bölümü için listeleme
Toplam kayıt 1, listelenen: 1-1
-
Personalized Treatment is Better Than One Treatment Fits All in the Management of Patients with Mcrc: A Consensus Statement
(Future Medicine Ltd, 2014)The VEGF- (bevacizumab) and EGFR- (cetuximab and panitumumab) targeting monoclonal antibodies have become integral components of the first-line treatment strategies for patients with metastatic colorectal cancer (mCRC). ...